RxDoctor Payments Data

Jeffrey Dakas, MD

Cardiovascular Disease · Poplar Bluff, MONPI 1336142256

Payments from drug & device makers

$296in general payments, 2019–2025

Across 16 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$68
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$55
  • Irhythm Technologies, Inc.$53
  • AstraZeneca$29
  • Boehringer Ingelheim$23
  • Pfizer$21
  • plus $48 from 3 others

What the payments were for

  • Food & beverage$296100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$296 in reported general payments places this provider in the 20th percentile of 391 cardiovascular disease providers in Missouri.

See all cardiovascular disease providers in Missouri

Medicare billing

Part B allowed, 2024
$2,553
Medicare patients
46
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Poplar Bluff

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →